Диссертация (1140247), страница 16
Текст из файла (страница 16)
Eken C, Oktay C, Bacanli A, et al. Anxiety and depressive disorders in patientspresenting with chest pain to the emergency department: a comparison betweencardiac and non-cardiac origin. Journal of Emergency Medicine 2010; 39:144150.62. Engel GL. The need for a new medical model: a challenge for biomedicine.Science 1977; 196:129-136.9663. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, riskfactors, impact and consulting – a population-based study. Aliment PharmacolTher 2003; 17:1115-1124.64. Eslick GD, Koloski NA, Talley NJ. Sexual, physical, verbal/emotional abuse andunex-plained chest pain.
Child Abuse Negl 2011; 35:601-605.65. Fagring AJ, Gaston-Johansson F, Kjellgren KI, et al. Unexplained chest pain inrelation to psychosocial factors and health-related quality of life in men andwomen. Eur J Cardiovasc Nurs 2007; 6:329-336.66. Farmer AD, Coen SJ, Kano M, et al. Psychological traits influence autonomicnervous system recovery following esophageal intubation in health andfunctional chest pain. Neurogastroenterol Motil 2013; 25:950-e772.67. Farre R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosaintegrity by the intraluminal impedance technique.
Gut 2011; 60:885-892.68. Fass R, Achem SR. Noncardiac chest pain: Epidemiology, natural course andpathogenesis. J Neurogastroenterol Motil 2011; 17:110-23.69. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil2006; 18:408-417.70. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acidexposureonmechanosensitivityandchemosensitivityinhumans.Gastroenterology 1998; 115:1363-1373.71. Fass R, Naliboff BD, Fass SS, et al. The effect of auditory stress on perception ofintraesophageal acid in patients with gastroesophageal reflux disease.Gastroenterology 2008; 134:696-705.72. Fass R, Sontag SJ, Traxler B, et al. Treatment of patients with persistentheartburn symptoms: a double-blind, randomized trial.
Clin GastroenterolHepatol 2006; 4: 50-56.73. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain.Gut 2002; 51:885-892.9774. Flook NW, Moayyedi P, Dent J, et al. Acid-suppressive therapy withesomeprazole for relief of unexplained chest pain in primary care: a randomized,double-blind, placebo-controlled trial. Am J Gastroenterol 2013; 108:56-64.75. Ford AC, Suares NC, Talley NJ. Meta-analysis: the epidemiology of noncardiacchest pain in the community. Aliment Pharmacol Ther 2011; 34:172-180.76. Fox M, Sweis R. Future directions in esophageal motility and function –newtechnology and methodology.
Neurogastroenterol Motil 2012; 24 Suppl 1:48-56.77. Frazzoni L, Frazzoni M, de Bortoli N, et al. Critical appraisal of Rome IVcriteria: hypersensitive esophagus does belong to gastroesophageal reflux diseasespectrum. Ann Gastroenterol. 2018 Jan-Feb; 31(1): 1–7.78. Frazzoni L, Frazzoni M, de Bortoli N, et al. Postreflux swallow-inducedperistaltic wave index and nocturnal baseline impedance can link PPI-responsiveheartburn to reflux better than acid exposure time. Neurogastroenterol Motil.2017; 29:e13116.79. Frazzoni M, Conigliaro R, Mirante VG, et al. The added value of quantitativeanalysis of on-therapy impedance-pH parameters in distinguishing refractorynon-erosive reflux disease from functional heartburn.
Neurogastroenterol Motil2012; 24:141-146.80. Frazzoni M, de Bortoli N, Frazzoni L, et al. Impairment of chemical clearanceand mucosal integrity distinguishes hypersensitive esophagus from functionalheartburn. J Gastroenterol. 2017; 52:444–451.81. Frazzoni M, de Bortoli N, Frazzoni L, et al. The added diagnostic value ofpostreflux swallow-induced peristaltic wave index and nocturnal baselineimpedance in refractory reflux disease studied with on-therapy impedance-pHmonitoring.
Neurogastroenterol Motil. 2017; 29:e12947.82. Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E.Impedance-pH monitoring for diagnosis of reflux disease: new perspectives. DigDis Sci. 2017; 62:1881–1889.83. Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G.Esophageal chemical clearance is impaired in gastro-esophageal reflux disease 98a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399–406.84. Frazzoni M, Savarino E, de Bortoli N, et al. Analyses of the post-reflux swallowinduced peristaltic wave index and nocturnal baseline impedance parametersincrease the diagnostic yield of impedance-pH monitoring of patients with refluxdisease. Clin Gastroenterol Hepatol.
2016; 14:40–46.85. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465.86. Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, et al.Prevalenceofeosinophilicesophagitisinpatientswithrefractorygastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis2011; 43:204-208.87.
Garcia-Compean D, Gonzalez MV, Galindo G, et al. Prevalence ofgastroesophageal reflux disease in patients with extraesophageal symptomsreferred from otolaryngology, allergy, and cardiology practices: a prospectivestudy. Dig Dis 2000; 18:178-182.88. Garros A, Mion F, Marjoux S, Damon H, Roman S. Factors associated withnonresponse to proton pump inhibitors therapy in patients referred foresophageal pH-impedance monitoring.
Dis Esophagus. 2015 May 8 doi:10.1111/dote.1237489. Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) andirritable bowel syndrome (IBS) – is it one disease or an overlap of two disorders?Dig Dis Sci 2009; 54:1829-34.90. Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation inclinical esophageal manometry: a quantitative analysis of 400 patients and 75controls. Am J Physiol Gastrointest Liver Physiol 2007; 293:G878-G885.91. Gibbs JF, Rajput A, Chadha KS, et al. The changing profile of esophageal cancerpresentation and its implication for diagnosis.
J Natl Med Assoc 2007; 99:620626.9992. Guillemot F, Ducrotte P, Bueno L. Prevalence of functional gastrointestinaldisorders in a population of subjects consulting for gastroesophageal refluxdisease in general practice. Gastroenterol Clin Biol 2005; 29:243-6.93. Gyawali CP, Bredenoord AJ, Conklin JL, et al. Evaluation of esophageal motorfunction in clinical practice. Neurogastroenterol Motil 2013; 25:99-133.94. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: theLyon Consensus Gut Published Online First: 03 February 2018.95.
Harar RP, Kumar S, Saeed MA, et al. Management of globus pharyngeus:review of 699 cases. J Laryngol Otol 2004; 118:522-527.96. Harris MB, Deary IJ, Wilson JA. Life events and difficulties in relation to theonset of globus pharyngis. J Psychosom Res 1996; 40:603-615.97. Hartono JL, Mahadeva S, Goh KL. Anxiety and depression in various functionalgastrointestinal disorders: do differences exist? J Dig Dis.
2012 May; 13(5):2527.98. Heitkemper M., Jarett M, Bond EF, Chang L. Impact of sex and gender onirritable bowel syndrome. Biol Res Nurs 2003; 5:56-65;99. Hill J, Stuart RC, Fung HK, et al. Gastroesophageal reflux, motility disorders,and psychological profiles in the etiology of globus pharyngis. Laryngoscope1997; 107: 1373-1377.100. Hoff DA, Gregersen H, Odegaard S, et al. Sensation evoked by esophagealdistension in functional chest pain patients depends on mechanical stress ratherthan on ischemia. Neurogastroenterol Motil 2010; 22:1170-1176, e1309-e1111.101. Hollerbach S, Bulat R, May A, et al.
Abnormal cerebral processing ofoesophageal stimuli in patients with noncardiac chest pain (NCCP).Neurogastroenterol Motil 2000; 12:555-565.102. Hsu CS, Liu TT, Wen SH, Wang CC, Yi CH, Chen JH, Lei WY, Orr WC, FabioP, Chen CL. Clinical, metabolic, and psychological characteristics in patientswith gastroesophageal reflux disease overlap with irritable bowel syndrome. EurJ Gastroenterol Hepatol. 2015 May; 27(5):516-22.100103. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impactof irritable bowel syndrome: An international survey of 40,000 subjects. AlimentPharmacol Ther 2003; 17:643-50.104. Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans LM, Bayati A,Simrén M.
Gastrointestinal-specific anxiety: an important factor for severity ofGI symptoms and quality of life in IBS. Neurogastroenterol Motil. 2010;22:646–e179.105. Jones MP, Dilley JB, Crowell MD, et al. Brain-gut connections in functional GIdisorders: anatomic and physiologic relationships. Neurogastroenterol Motil2006; 18:91-103.106. Jones R, Lydeard S. Irritable bowel syndrome in the general population.
BMJ1992; 304:87-90.107. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, etal. Overlap of gastrooesophageal reflux disease and irritable bowel syndrome:Prevalence and risk factors in the general population. Aliment Pharmacol Ther2007; 26:453-61.108. Jung НУ, Puckett JL, Bhalla V, et al.
Asynchrony between the circular and thelongitudinal muscle contraction in patients with nutcracker esophagus.Gastroenterology 2005; 128:1179-1186.109. Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, et al.Prevalence of overlaps between GERD, FD and IBS and impact on healthrelated quality of life. J Gastroenterol Hepatol 2010; 25:1151-6.110. Kamath MV, May A, Hollerbach S, et al. Effects of esophageal stimulation inpatients with functional disorders of the gastrointestinal tract. Crit Rev BiomedEng 2000; 28: 87-93.111.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
